Skip to main content

Advertisement

Log in

The role of human xanthine oxidoreductase (HXOR), anti-HXOR antibodies, and microorganisms in synovial fluid of patients with joint inflammation

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This work is to investigate the levels of human xanthine oxidoreductase (HXOR), its antibodies, and microorganisms in synovial fluid of patients with untreated rheumatoid joint diseases. Synovial fluids were collected from sixty-four patients with rheumatoid joint diseases. Sixty-four age-matched individuals were included as control. Xanthine oxidoreductase (XOR) proteins level and anti-XOR antibodies were determined in the blood and synovial fluid, using human XOR as antigen, by enzyme-linked immunosorbent (ELISA) assay. Synovial fluids were cultured for bacteria and fungi. The titers of XOR protein in the synovial fluid of patients with rheumatoid arthritis were 90.43 ± 23.37 μg/ml (mean ± SD, n = 29) and up to 62.42 ± 8.74 μg/ml (mean ± SD, n = 35) in other joint inflammation. Anti-HXOR antibodies titers in patients were 167.72 ± 23.64 μg/ml, n = 64, which was significantly higher in rheumatoid arthritis patients. The results indicated that anti-HXOR antibodies in synovial fluids have a protective role as high concentrations against XOR were detected in inflammatory arthritis. These antibodies play a role in eliminating XOR from synovial fluids. However, immune complex formation could activate complement and participate in propagating the inflammatory cycle. Synovial aspirate ordinary microbial cultures were negative for any bacteria or fungi, but that does not exclude organisms of special culture requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chung HY, Baek BS, Song SH, Kim MS, Huh JI, Shim KH, Kim KW, Lee KH (1997) Xanthine dehydrogenase/xanthine oxidase and oxidative stress. Age 20:127–140

    Article  CAS  Google Scholar 

  2. Cheng-xing S, Hao-zhu C, Jun-bo G (2004) The role of inflammatory stress in acute coronary syndrome. Chin Med J 117:133–139

    Google Scholar 

  3. Dawson J, Walters M (2006) Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease. Br J Clin Pharmacol 62:633–644

    Article  PubMed  CAS  Google Scholar 

  4. Carty SM, Snowden N, Silman AJ (2000) Should infection still be considered as the most likely triggering factor for rheumatoid arthritis. Ann Rheum Dis 63:ii46–ii49

    Google Scholar 

  5. Griffiths DJ (2000) Rheumatoid arthritis: a viral aetiology? Hosp Med 61:378–379

    PubMed  CAS  Google Scholar 

  6. Masuko-Hongo K, Kato T, Nishioka K (2003) Virus-associated arthritis. Best Pract Res Clin Rheumatol 17:309–318

    Article  PubMed  Google Scholar 

  7. Phillips PE (1997) Viral arthritis. Curr Opin Rheumatol 9:337–344

    Article  PubMed  CAS  Google Scholar 

  8. Zhang L, Nikkari S, Skurnik M, Ziegler T, Luukainen R, Mottonen T, Toivanen P (1993) Detection of herpes viruses by polymerase chain reaction in lymphocytes frm patients with rheumatoid arthritis. Arthritis Rheum 36:1080–1086

    Article  PubMed  CAS  Google Scholar 

  9. Naides SJ (1998) Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 24:375–401

    Article  PubMed  CAS  Google Scholar 

  10. Katsumi E (1999) Involvement of viral infection in rheumatoid arthritis. Pharma Med 17:19–26

    Google Scholar 

  11. Hasunuma T, Sumida T, Nishioka K (1998) Human T cell leukemia virus type-1 and rheumatoid arthritis. Int Rev Immunol 17:291–307

    Article  PubMed  CAS  Google Scholar 

  12. Zweier JL (1988) Measurement and characterization of post-ischemic free radical generation in isolated perfused heart. J Biol Chem 263:1353–1357

    PubMed  CAS  Google Scholar 

  13. Kennedy TP, Rao NV, Hopkins C, Pennington L, Tolley E, Hoidal JR (1989) Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest 83:1326–1335

    Article  PubMed  CAS  Google Scholar 

  14. Sussman MS, Bulkley GB (1990) Oxygen-derived free radicals in reperfusion injury. Methods Enzymol 186:711–723

    Article  PubMed  CAS  Google Scholar 

  15. Miesel R, Zuber M (1993) Elevated levels of xanthine oxidase in serum of patients with inflammatory and auto-immune rheumatic diseases. Inflammation 17:551–560

    Article  PubMed  CAS  Google Scholar 

  16. Blake DR, Stevens CR, Sahinoglu T, Ellis G, Gaffney K, Edmonds S, Benboubetra M, Harrison R, Jawed S, Kanczler J, Millar TM, Winyard PG, Zhang Z (1997) Xanthine oxidase; four roles for the enzyme in rheumatoid pathology. Biochem Soc Trans 25:812–816

    PubMed  CAS  Google Scholar 

  17. Stevens CR, Benboubetra M, Harrison R, Sahinoglu T, Smith EC, Blake DR (1991) Localization of xanthine oxidase to synovial endothelium. Ann Rheum Dis 50:760–762

    Article  PubMed  CAS  Google Scholar 

  18. Bray RC (1975) Molybdenum iron-sulfur flavin hydroxylases and related enzymes. In: Boyer PD (ed) The enzymes. Academic Press, New York, pp 299–419

  19. Harrison R (2002) Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33:774–797

    Article  PubMed  CAS  Google Scholar 

  20. Martin HM, Hancock JT, Salisbury V, Harrison R (2004) Role of xanthine oxidoreductase as an antimicrobial agent. Infect Immun 72:4933–4939

    Article  PubMed  CAS  Google Scholar 

  21. Khan AU, Wilson T (1995) Reactive oxygen species as cellular messengers. Chem Biol 2:437–445

    Article  PubMed  CAS  Google Scholar 

  22. Sanders SA, Eisenthal R, Harrison R (1997) NADH oxidase activity of human xanthine oxidoreductase—generation of superoxide anion. Eur J Biochem 245:541–548

    Article  PubMed  CAS  Google Scholar 

  23. Baghiani A, Harrison R, Benboubetra M (2003) Purification and partial characterization of camel milk xanthine oxidoreductase. Arch Physiol Biochem 111:407–414

    Article  PubMed  CAS  Google Scholar 

  24. Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW (1981) Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 25:67–82

    Article  PubMed  CAS  Google Scholar 

  25. Meneshian A, Bulkley GB (2002) The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 9:162–175

    Google Scholar 

  26. Kundalic S, Kocic G, Cosic V, Jevtovic-stoimenova T, Dordevic VB (2003) The role of xanthine dehydrogenase l xanthine oxidase in atherogenesis in patients with hyperlipidaemia. Jugoslov Med biochem 22:151–158

    Article  CAS  Google Scholar 

  27. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular diseases: molecular mechanisms and pathophysiology. J Physiol 555:589–606

    Article  PubMed  CAS  Google Scholar 

  28. Mitchell KL, Pisetsky DS (2007) Early rheumatoid arthritis. Curr Opin Rheumatol CME 19:278–283

    Article  Google Scholar 

  29. Machold KP, Stamm TA, Eberl GJM, Nell VKP, Dunky A, Uffmann M et al (2002) Very recent onset arthritis: clinical, laboratory, and radiological findings during the first year disease. J Rheumatol 29:2278–2287

    PubMed  Google Scholar 

  30. Hichon CA, Peschken CA, Shaikh S, El-Gabalawy HS (2005) Early undifferentiated arthritis. Rheum Dis Clin N Am 31:605–626

    Article  Google Scholar 

  31. Van Aken J, Van Dongen H, Le Cessie S, Allaart CF, Breedveld FC, Huizinga TWJ et al (2006) Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 65:20–25

    Article  PubMed  Google Scholar 

  32. Kary S, Fritz J, Scherer HU, Burmester GR (2004) Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study. Rheumatology 43:819–820

    Article  PubMed  CAS  Google Scholar 

  33. Oster KA, Oster JB, Ross DJ (1975) Immune response to bovine xanthine oxidase in atherosclerotic patients. Am Lab 6:41–47

    Google Scholar 

  34. Bruder G, Jarasch ED, Heid HW (1984) High concentration of antibodies to xanthine oxidase in human and animal sera. J Clin Invest 74:783–794

    Article  PubMed  CAS  Google Scholar 

  35. Harrison R, Benboubetra M, Bryson S, Thomas RD, Elwood PC (1990) Antibodies to xanthine oxidase: elevated levels in patients with acute myocardial infarction. Cardioscience 1:183–189

    PubMed  CAS  Google Scholar 

  36. Ng YLE, Lewis WHP, Chui SH (1990) Enzyme linked immunosorbent assay for determination of antibodies to xanthine oxidase. Med Lab Invest 47:30–35

    CAS  Google Scholar 

  37. Ng YLE, Lewis WHP (1994) Circulating immune complexes of xanthine oxidase in normal subjects. Br J Biomed Sci 51:124–127

    PubMed  CAS  Google Scholar 

  38. Benboubetra M, Gleeson A, Harris CPD, Khan J, Arrar L, Brennand D et al (1997) Circulating anti-(xanthine oxidoreductase) antibodies in healthy human adults. Eur J Clin Invest 27:611–619

    Article  PubMed  CAS  Google Scholar 

  39. Venn AJ, Dresser DW (1987) Limitation of haemolytic plaque assay for IgG anti-IgG rheumatoid factor-producing cells. J Immunol Meth 102:195–204

    Article  CAS  Google Scholar 

  40. Simon L, Claustre J, Picard JJ, Marty M, Blotman F (1972) Intra-articular osteoid osteoma of the elbow. Rheumatologie 24:377–382

    CAS  Google Scholar 

  41. Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265–336

    Article  PubMed  CAS  Google Scholar 

  42. Palmer DG, Hogg N, Revell PA (1986) Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodies. Pathology 18:431–437

    Article  PubMed  CAS  Google Scholar 

  43. Zubler RH, Nydegger U, Perrin LH, Fehr K, McCormick J, Lambert PH, Miescher PA (1976) Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-CIq binding activity with clinical and biological features of the disease. J Clin Invest 57:1308–1319

    Article  PubMed  CAS  Google Scholar 

  44. Godber BLJ, Schwarz G, Mendel RR, Lowe DJ, Bray RC, Eisenthal R, Harrison R (2005) Molecular characterization of human xanthine oxidoreductase: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres. Biochem J 388:501–508

    Article  PubMed  CAS  Google Scholar 

  45. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantitative of proteins. Anal Biochem 72:248–254

    Article  PubMed  CAS  Google Scholar 

  46. Avis PG, Bergel F, Bray RC (1956) Cellular constituents. The chemistry of xanthine oxidase. Part III. Estimations of the cofactors and the catalytic functions of enzyme fractions of cows’ milk. J Chem Soc (Perkins I):1219–1226

  47. Rousseaux-Prevost R, De Almeida M, Arrar L, Hublau P, Rousseaux J (1989) Antibodies to sperm basic nuclear protein detected in infertile patients by dot-immunobinding and ELISA. Am J Reprod Immunol 20:17–20

    PubMed  CAS  Google Scholar 

  48. Allen RE, Outhwaite JM, Morris CJ, Blake DR (1987) Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis 46:843–845

    Article  PubMed  CAS  Google Scholar 

  49. Parks DA, Granger DN (1986) Xanthine oxidase: biochemistry distribution and physiology. Acta Physiol Scand Suppl 548:87–99

    PubMed  CAS  Google Scholar 

  50. Arrar L, Hanachi N, Rouba K, Charef N, Khennouf S, Baghiani A (2008) Anti-xanthine oxidase antibodies in sera and synovial fluid of patients with rheumatoid arthritis and other joint inflammations. Saudi Med J 29:803–807

    PubMed  Google Scholar 

  51. Hanachi N, Charef N, Baghiani A, Khennouf S, Derradji Y, Boumerfeg s et al (2009) Comparison of xanthine oxidase levels in synovial fluid from patients with rheumatoid arthritis and other joint inflammations. Saudi Med J 30:1422–1425

    PubMed  Google Scholar 

  52. Abadeh S, Killacky J, Benboubetra M, Harrison R (1992) Purification and partial characterization of xanthine oxidase from human milk. Biochem Biophys Acta 1117:25–32

    Article  PubMed  CAS  Google Scholar 

  53. Yamomoto T, Moriwaki Y, Takahashi S et al (1996) Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. J Chromatogr B 681:395–400

    Article  Google Scholar 

  54. Hall GS, Gordon S, Schroeder S, Smith K, Anthony K, Procop W (2001) Case of synovial potentially caused by Dolosigranulum pigrum. J Clin Microbiol 39:1202–1203

    Article  PubMed  CAS  Google Scholar 

  55. Ogrendik M (2009) Rheumatoid arthritis is linked to oral bacteria: etiology association. Modern Rheumatol 19:453–456

    Article  Google Scholar 

  56. Schaeverbeke T, Renaudin H, Clerc M, Lequen L, Vernhes JP, De Barbeyrac B, Bannwarth B, Bebear CH, Dehais J (1997) Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples. Br J Rheum 36:310–314

    Article  CAS  Google Scholar 

  57. Newkirk, MM, Goldbach-Mausky, R, Senior, BW, Klippel, J, Schumucher, HR, Al-Gebalawy, HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to E. coli are associated with early RF-positive rheumatoid arthritis. Rheumatology 44(11):1433–1441

    Google Scholar 

  58. Tani Y, Tiwana H, Hukudu S, Nishioka J, Fielder M, Wilson C, Bausal S, Ebriager A (1997) Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with Ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24(1):109–114

    Google Scholar 

  59. Senior BW, Anderson GA, Mortey KD, Kerv MA (1999) Evidence the patients with rheumatoid arthritis have a symptomatic non-significant Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 38(2):99–106

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Najah Al-Muhtaseb.

Additional information

N. Al-Muhtaseb and E. Al-Kaissi contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Muhtaseb, N., Al-Kaissi, E., Thawaini, A.J. et al. The role of human xanthine oxidoreductase (HXOR), anti-HXOR antibodies, and microorganisms in synovial fluid of patients with joint inflammation. Rheumatol Int 32, 2355–2362 (2012). https://doi.org/10.1007/s00296-011-1965-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1965-0

Keywords

Navigation